WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006084688) HIV protease inhibitors
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/084688    International Application No.:    PCT/EP2006/001135
Publication Date: 17.08.2006 International Filing Date: 09.02.2006
IPC:
C07C 271/22 (2006.01), C07C 311/06 (2006.01), C07C 275/24 (2006.01), C07D 213/42 (2006.01), C07D 241/12 (2006.01), C07D 333/58 (2006.01), C07D 317/58 (2006.01), C07D 261/08 (2006.01), A61K 31/18 (2006.01), A61K 31/17 (2006.01), A61K 31/325 (2006.01), A61K 31/38 (2006.01), A61K 31/42 (2006.01), A61K 31/44 (2006.01), A61K 31/495 (2006.01)
Applicants: MEDIVIR AB [SE/SE]; Lunastigen 7, SE-141 44 Huddinge (SE) (For All Designated States Except US).
TIBOTEC PHARMACEUTICALS LTD. [IE/IE]; Eastgate Village, Eastgate, Little Island, Co Cork (IE) (AM, AZ, BF, BJ, BW, BY, CF, CG, CI, CM, GA, GH, GM, GN, GQ, GW, ID, KE, KG, KZ, LS, MD, ML, MR, MW, MZ, NA, NE, NZ, PH, RU, SD, SG, SL, SN, SZ, TD, TG, TJ, TM, TZ, UA, UG, VN, ZM, ZW only).
EKEGREN Jenny [SE/SE]; (SE) (For US Only).
HALLBERG, Anders [SE/SE]; (SE) (For US Only).
WALLBERG, Hans [SE/SE]; (SE) (For US Only).
SAMUELSSON, Bertil [SE/SE]; (SE) (For US Only).
KANNAN, Mahalingan [IN/SE]; (SE) (For US Only)
Inventors: EKEGREN Jenny; (SE).
HALLBERG, Anders; (SE).
WALLBERG, Hans; (SE).
SAMUELSSON, Bertil; (SE).
KANNAN, Mahalingan; (SE)
Agent: AWAPATENT AB; P.O. Box 45086, SE-104 30 Stockholm (SE)
Priority Data:
0500307-4 10.02.2005 SE
0502352-8 25.10.2005 SE
0502468-2 08.11.2005 SE
Title (EN) HIV protease inhibitors
(FR) INHIBITEURS DE LA PROTEASE DU VIH
Abstract: front page image
(EN)Compounds of the formula (I): Wherein R1, R2, X and N are as defined in the specification; E is N, CH; A1 and A' are terminal groups as defined in the specification. The compounds have utility as HIV-I protease inhibitors.
(FR)La présente invention concerne des composés répondant à la formule (I), dans laquelle R1, R2, X et N sont conformes à la définition indiquée dans la description ; E représente N, CH ; A1 et A' représentent des groupes terminaux conformément à la définition dans la description. Ces composés ont une utilité en tant qu'inhibiteurs de la protéase du VIH-I.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)